Oncotelic Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Oncotelic Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Oncotelic Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $0.000.
  • Oncotelic Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $0.000, a 100% decline from 2022.
  • Oncotelic Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $900K, unchanged from 2021.
  • Oncotelic Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $900K.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 -$900K -100% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-12
2022 $900K $0 0% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-12
2021 $900K +$900K Jan 1, 2021 Dec 31, 2021 10-K/A 2023-04-20
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-04-15
2018 $744K -$91K -10.9% Jan 1, 2018 Dec 31, 2018 10-K 2019-04-10
2017 $835K +$31K +3.86% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-10
2016 $804K -$2K -0.25% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-17
2015 $806K +$392K +94.7% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 $414K -$265K -39% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-25
2013 $679K +$168K +32.9% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-30
2012 $511K -$340K -40% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-30
2011 $851K +$1.54M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-20
2010 -$687K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.